APOMAB®, a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy

BACKGROUND: Antineoplastic therapy may impair the survival of malignant cells to produce cell death. Consequently, direct measurement of tumor cell death in vivo is a highly desirable component of therapy response monitoring. We have previously shown that APOMAB® representing the DAB4 clone of a La/...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Ejeh, Fares, Darby, Jocelyn M., Tsopelas, Chris, Smyth, Douglas, Manavis, Jim, Brown, Michael P.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645692/
https://www.ncbi.nlm.nih.gov/pubmed/19247492
http://dx.doi.org/10.1371/journal.pone.0004558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645692/
https://www.ncbi.nlm.nih.gov/pubmed/19247492
http://dx.doi.org/10.1371/journal.pone.0004558

Ejemplares similares